Scientists have developed a new CAR T-cell immunotherapy strategy that uses light to activate the immune cells specifically in cancerous regions. The approach, which worked well in mice, may help reduce treatment-related side effects in cancer patients. The study, “Engineering light-controllable CAR T cells for cancer immunotherapy,” was published in the journal Science Advances. Chimeric antigen receptor T-cell therapy, or simply CAR T-cell therapy, is a type of immunotherapy that uses a person’s own T-cells…
You must be logged in to read/download the full post.
The post New Light-activated CAR T-cells May Help Reduce Therapy Side Effects appeared first on BioNewsFeeds.